Grimaud Brett A. (CIK 1966698) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-24). Recent activity: Sell TBPH (223,917 shares), Sell TBPH (107,812 shares), Sell TBPH (23,439 shares), Sell TBPH (7,952 shares), Sell TBPH (8,829 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 223,917 | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 107,812 | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 23,439 | $0 |
| 2026-08-24 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 7,952 | $134,786 |
| 2026-05-22 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 8,829 | $146,120 |
| 2026-04-03 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Buy | 37,500 | $0 |
| 2026-02-24 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 20,833 | $409,577 |
| 2025-11-24 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 19,024 | $340,530 |
| 2025-08-22 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 9,762 | $130,713 |
| 2025-05-22 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 9,743 | $92,071 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24